News from NORD

Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium


 

NORD Chief Operating Officer Pamela Gavin will speak at a symposium to be hosted by the University of Rochester on May 12 on Technology and Rare Neurological Diseases . Registration is open for this event, which will focus on novel applications of technology to accelerate the development of new therapeutics for individuals with rare neurological diseases.

Recommended Reading

NORD Submits Letter to Congress on Pre-Existing Conditions
MDedge Hematology and Oncology
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
MDedge Hematology and Oncology
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
MDedge Hematology and Oncology
Safety of N9-GP for hemophilia B needs further study, FDA committee agrees
MDedge Hematology and Oncology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Hematology and Oncology
NORD and Neurology Reviews Publish Special Report
MDedge Hematology and Oncology
Save the Date for the 2017 NORD Summit
MDedge Hematology and Oncology
Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Hematology and Oncology
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Hematology and Oncology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Hematology and Oncology